Weiwei Gao

Weiwei Gao

Auto-generated profile, based on publicly available information

Weiwei Gao

Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, Shu and K.C. Chien and Peter Farrell Collaboratory, University of California San Diego, La Jolla, California 92093, United States

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
JZJia Zhuang
Jia Zhuang
HGHua Gong
Hua Gong
JZJiarong Zhou
Jiarong Zhou
QZQiangzhe Zhang
Qiangzhe Zhang
WGWeiwei Gao
Weiwei Gao
LZLiangfang Zhang
Liangfang Zhang
Platelet-mimicking nanoparticles enable the targeted delivery of small interfering RNA to tumors for anticancer therapy.

31 March 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
BBBaharak Bahmani
Baharak Bahmani
HGHua Gong
Hua Gong
BLBrian T. Luk
Brian T. Luk
KHKristofer J. Haushalter
Kristofer J. Haushalter
EDEthel DeTeresa
Ethel DeTeresa
JZJie Zhang
Jie Zhang
Intratumoral immunotherapy is an emerging modality for the treatment of solid tumors. Toll-like receptor (TLR) agonists have shown promise for eliciting immune responses, but systemic administration often results in the development of adverse side effects. Herein, we investigate whether localized delivery of the TLR agonist, resiquimod (R848), via platelet membrane-coated nanoparticles (PNP-R848) elicits antitumor responses. The membrane coating provides a means of enhancing interactions with the tumor microenvironment, thereby maximizing the activity of R848. Intratumoral administration of PNP-R848 strongly enhances local immune activation and leads to complete tumor regression in a colorectal tumor model, while providing protection against repeated tumor re-challenges. Moreover, treatment of an aggressive breast cancer model with intratumoral PNP-R848 delays tumor growth and inhibits lung metastasis. Our findings highlight the promise of locally delivering immunostimulatory payloads using biomimetic nanocarriers, which possess advantages such as enhanced biocompatibility and natural targeting affinities.

9 September 2020 in Small Structures
Verified
Journal Article
Open access
PDF file
SWShuyan Wang
Shuyan Wang
YDYaou Duan
Yaou Duan
QZQiangzhe Zhang
Qiangzhe Zhang
AKAnvita Komarla
Anvita Komarla
HGHua Gong
Hua Gong
LZLiangfang Zhang
Liangfang Zhang
Platelets exhibit distinct surface moieties responsible for modulating their adhesion to various disease‐relevant substrates involving vascular damage, immune evasion, and pathogen interactions. Such broad biointerfacing capabilities of platelets have inspired the development of platelet‐mimicking drug carriers that preferentially target drug payloads to disease sites for enhanced therapeutic efficacy. Among these carriers, platelet membrane–coated nanoparticles (denoted “PNPs”) made by cloaking synthetic substrates with the plasma membrane of platelets have emerged recently. Their “top‐down” design combines the functionalities of natural platelet membrane and the engineering flexibility of synthetic nanomaterials, which together create synergy for effective drug delivery and novel therapeutics. Herein, the recent progress of engineering PNPs with different structures for targeted drug delivery is reviewed, focusing on three areas, including targeting injured blood vessels to treat vascular diseases, targeting cancer cells for cancer treatment and detection, and targeting drug‐resistant bacteria to treat infectious diseases. Overall, current studies establish PNPs as versatile nanotherapeutics for drug targeting with strong potentials to improve the treatment of various diseases.

18 June 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
JPJoon Ho Park
Joon Ho Park
YJYao Jiang
Yao Jiang
JZJiarong Zhou
Jiarong Zhou
HGHua Gong
Hua Gong
AMAnimesh Mohapatra
Animesh Mohapatra
LZLiangfang Zhang
Liangfang Zhang
Genetically engineered cell membrane–coated nanoparticles enable targeted drug delivery to sites of inflammation.

30 October 2023 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
NKNishta Krishnan
Nishta Krishnan
YJYao Jiang
Yao Jiang
JZJiarong Zhou
Jiarong Zhou
AMAnimesh Mohapatra
Animesh Mohapatra
FPFei-Xing Peng
Fei-Xing Peng
LZLiangfang Zhang
Liangfang Zhang

28 September 2022 in Science Robotics
Verified
Journal Article
Closed access
FZFangyu Zhang
Fangyu Zhang
ZLZhengxing Li
Zhengxing Li
YDYaou Duan
Yaou Duan
AAAmal Abbas
Amal Abbas
RMRodolfo Mundaca-Uribe
Rodolfo Mundaca-Uribe
Joseph WangJoseph Wang
Joseph Wang
The use of micromotors for active drug delivery via oral administration has recently gained considerable interest. However, efficient motor-assisted delivery into the gastrointestinal (GI) tract remains challenging, owing to the short propulsion lifetime of currently used micromotor platforms. Here, we report on an efficient algae-based motor platform, which takes advantage of the fast and long-lasting swimming behavior of natural microalgae in intestinal fluid to prolong local retention within the GI tract. Fluorescent dye or cell membrane–coated nanoparticle functionalized algae motors were further embedded inside a pH-sensitive capsule to enhance delivery to the small intestines. In vitro, the algae motors displayed a constant motion behavior in simulated intestinal fluid after 12 hours of continuous operation. When orally administered in vivo into mice, the algae motors substantially improved GI distribution of the dye payload compared with traditional magnesium-based micromotors, which are limited by short propulsion lifetimes, and they also enhanced retention of a model chemotherapeutic payload in the GI tract compared with a passive nanoparticle formulation. Overall, combining the efficient motion and extended lifetime of natural algae–based motors with the protective capabilities of oral capsules results in a promising micromotor platform capable of achieving greatly improved cargo delivery in GI tissue for practical biomedical applications.